Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. With the data to train, the AI to create, and the wet lab to validate, our Integrated Drug Creation platform aims to engineer better biologics with design-in functionality and best-in-class properties.
![Absci logo](/files/LOGO/1672688-ABSI.png)
Company profile
Ticker
ABSI
Exchange
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Icon • Syneos Health • Medpace • Incyte • Zymergen • OmniAb ...
Former names
AbSci, LLC
SEC CIK
Corporate docs
Subsidiaries
AbSci, LLC • Absci GmbH • Target Discovery Merger Sub II, LLC • De Novo Design, LLC • Absci Ltd • Absci d.o.o. ...
IRS number
453931977
ABSI stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 24
10-Q
2024 Q1
Quarterly report
14 May 24
8-K
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
14 May 24
ARS
2024 FY
Annual report to shareholders
23 Apr 24
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
S-8
Registration of securities for employees
21 Mar 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
21 Mar 24
8-K
Absci Announces Proposed Public Offering of Common Stock
28 Feb 24
Latest ownership filings
4
Amrit Nagpal
14 Jun 24
4
Jeremy Green
14 Jun 24
4
Zachariah Jonasson
14 Jun 24
4
Menelas N Pangalos
14 Jun 24
4
Daniel A Rabinovitsj
14 Jun 24
4
Joseph Sirosh
14 Jun 24
4
KAREN K MCGINNIS
14 Jun 24
4
HOUTEN FRANS VAN
14 Jun 24
144
Notice of proposed sale of securities
13 Jun 24
4
Change in insider ownership
28 May 24
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 76.31 mm | 76.31 mm | 76.31 mm | 76.31 mm | 76.31 mm | 76.31 mm |
Cash burn (monthly) | 4.45 mm | (no burn) | 7.83 mm | 9.54 mm | 5.95 mm | 5.20 mm |
Cash used (since last report) | 11.57 mm | n/a | 20.36 mm | 24.80 mm | 15.47 mm | 13.51 mm |
Cash remaining | 64.73 mm | n/a | 55.95 mm | 51.50 mm | 60.83 mm | 62.80 mm |
Runway (months of cash) | 14.5 | n/a | 7.1 | 5.4 | 10.2 | 12.1 |
Institutional ownership, Q1 2024
13F holders | Current |
---|---|
Total holders | 60 |
Opened positions | 36 |
Closed positions | 16 |
Increased positions | 4 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 156.03 bn |
Total shares | 181.01 mm |
Total puts | 31.90 k |
Total calls | 398.30 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Phoenix Venture Partners II | 144.93 mm | $0.00 |
FMR | 14.81 mm | $84.12 bn |
Redmile | 8.28 mm | $45.22 mm |
Vanguard | 3.45 mm | $19.57 bn |
ARK Investment Management | 3.28 mm | $18.61 bn |
BLK Blackrock | 899.63 k | $5.11 bn |
Platinum Investment Management | 776.60 k | $4.41 bn |
Geode Capital Management | 686.16 k | $3.90 bn |
Susquehanna International | 518.50 k | $2.95 bn |
CMTDF Sumitomo Mitsui Trust | 420.81 k | $2.39 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 24 | Zachariah Jonasson | Common Stock | Sell | Dispose S | No | No | 4.9797 | 19,859 | 98.89 k | 384,751 |
13 Jun 24 | Zachariah Jonasson | Common Stock | Option exercise | Acquire M | No | No | 3.39 | 28,700 | 97.29 k | 404,610 |
13 Jun 24 | Zachariah Jonasson | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.39 | 28,700 | 97.29 k | 0 |
12 Jun 24 | Frans Van Houten | Common Stock | Grant | Acquire A | No | No | 0 | 8,820 | 0.00 | 8,820 |
12 Jun 24 | Frans Van Houten | Stock Option Common Stock | Grant | Acquire A | No | No | 4.96 | 36,274 | 179.92 k | 36,274 |
12 Jun 24 | Mcginnis Karen K | Common Stock | Grant | Acquire A | No | No | 0 | 8,820 | 0.00 | 23,820 |
12 Jun 24 | Mcginnis Karen K | Stock Option Common Stock | Grant | Acquire A | No | No | 4.96 | 36,274 | 179.92 k | 36,274 |
12 Jun 24 | Menelas N Pangalos | Common Stock | Grant | Acquire A | No | No | 0 | 3,675 | 0.00 | 3,675 |
12 Jun 24 | Menelas N Pangalos | Stock Option Common Stock | Grant | Acquire A | No | No | 4.96 | 15,114 | 74.97 k | 15,114 |
12 Jun 24 | Rabinovitsj Daniel A | Common Stock | Grant | Acquire A | No | No | 0 | 8,820 | 0.00 | 8,820 |
News
AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session
17 Jun 24
Cathie Wood-Led Ark Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
29 May 24
The Analyst Verdict: Absci In The Eyes Of 6 Experts
15 May 24
HC Wainwright & Co. Reiterates Buy on Absci, Maintains $7 Price Target
15 May 24
Absci Q1 2024 GAAP EPS $(0.22) Misses $(0.21) Estimate, Sales $898.000K Miss $2.419M Estimate
14 May 24
Press releases
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
14 May 24
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
16 Apr 24
Thinking about buying stock in Curiositystream, Capricor Therapeutics, PowerFleet, Absci, or Nano-X Imaging?
25 Mar 24
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
21 Mar 24